The Medical Laboratory Science Council of Nigeria has sealed a laboratory that operated for nearly 15 years in the Federal Capital Territory (FCT) for “unethical practices.”

The police have also arrested a nurse f r conducting tests in a pharmacy.

Inspectors from the council on unscheduled visit to the laboratory in Nyanya area of FCT, found the laboratory had no provisions for safety or proper disposal of waste, no signage and was run by a microbiologist, one Isaac Akinrinola.

The laboratory, one of nearly a dozen inspected has operated in a slum neighborhood of Nyanya since 2000 and was faulted for sterilizing sample bottles in a makeshift box.

The Registrar of the council, Anthony Emeribe, said complete and side laboratories operating in hospitals, apart from private ones, will also come under inspection.

http://onlinemedicalgists..com/2015/03/regulator-seals-laboratory.html

The attention of the general public is hereby drawn to a recent publication by the national health insurance scheme (NHIS), in The Guardian (Page 55), Daily Sun (Page 50) and Daily Trust (Page 22), all of Tuesday, February 24, 2015,inviting applications from suitably qualified candidates to fill the following positions in the organization:

i. General Manager, Contribution Management (NHIS/GM/001)
ii. General Manager, Finance & Accounts (NHIS/GM/002)
iii. General Manager, Standard & Quality Assurance (NHIS/GM/003)
iv. General Manager, Formal Sector (NHIS/GM/004)
v. General Manager, Informal Sector (NHIS/GM/005)
vi. General Manager, Planning, Research & Monitoring (NHIS/GM/006)
vii. General Manager, Human Resource & Administration (NHIS/GM/007)
viii. General Manager, Procurement (NHIS/GM/008)
ix. General Manager, Marketing (NHIS/GM/009)
x. General Manager, Audit (NHIS/GM/01 0)
xi. General Manager, Legal Services (NHIS/GM/011)

All concerned should please note that the closing date for the submission of applications has been extended by four (4) weeks.
Consequently, the effective closing date for submission of applications/CVs is now Wednesday,April 8, 2015. The general public is requested to please take note of the extension.

Signed
Management

http://onlinemedicalgists..com/2015/03/national-health-insurance-scheme-public-notice.html

Applications are hereby invited from suitably qualified candidates to fill the following positions in Obafemi Awolowo University, Ile-Ife.

A) ACADEMIC POSITIONS
1)FACULTY OF BASIC MEDICAL SCIENCES

Department of Anatomy and Cell Biology

Area of SpecializationAnatomy
Position

Lecturer II - CONUASS 03

Candidates applying for the position of Lecturer II must possess M.Sc in Anatomy or M.BBS/Bch.D from a reputable University.

B SENIOR NON-TEACHING POSITION

Department of Anatomy and Cell Biology

Position

Technologist II CONTISS 07 (N1,084,016-N1,600, 307)

Candidate applying for the position of Technologist II must possess HND/ANIST/AIMLT, B.SC/B.Tech with additional training in Histology and Laboratory Management and must be a registered member of NISLT or MLSCN.

Method of Application

Applicants for Academic and the Senior non-teaching Staff positions are required to submit 35 copies of their applications and up-to-date curriculum vitae giving the following information in order as listed below:

(i) Full Name (Surname first in capital letters).

(ii) Post Applied for.

(iii) Date and place of birth (attach birth certificate/sworn affidavit).

(iv) Nationality.

(v) State of Origin, Senatorial District and Local Government Area (if a Nigerian)

(vi) Contact Details (Home Address, Postal Address/E-mail address(es)/ Mobile Phone Numbers).

(vii) Marital Status.

(viii) Number of Children and their Ages.

(ix) Next Kin

(x) Contact Details of next of Kin (Home Address, Postal Address/E-mail address(es)/ Mobile Phone Numbers).

(xi) Institutions attended with dates.

(xii) Academic/Professional qualifications and distinctions obtained with dates (attach copies of credentials).

(xiii) Work Experience with dates.

(xiv) Present Employment, Status and Salary (if any).

(xv) Research interests and activities

(xvi) Conference/ courses attended (state titles of papers presented if any).

(xvii) Professional accomplishment.

(xviii) Publications with date.

(xix) Service to national and international bodies.

(xx) Extra Curricular Activities.

(xxi) Any physical challenge?

(xxii) Names and address of three (3) referees who must have been closely associated with candidate’s academic/work experience.

NOTE: (xv) – (xvii) are for candidates applying for lectureship positions only.

Candidates applying for any of the positions are advised to request their referees to forward confidential reports on them directly to the Registrar. The reports should be duly marked “CONFIDENTIAL”.

CLOSING DATE: Applications and curriculum vitae of all interested candidates are to be forwarded to the Registrar, Obafemi Awolowo University, Ile-Ife, “for the attention of Director of Personnel Affairs” not later than six (6) weeks from the date of this advertisement. Candidates are also required to forward a soft copy of their application and curriculum vitae by e-mail (as an attachment) to [email]registra@oauife.edu.ng[/email] within the specified period. Only the applications of candidates short-listed will be acknowledged.

DOTUN AWOYEMI
REGISTRAR

http://onlinemedicalgists..com/2015/03/vacancies-at-obafemi-awolowo-university.html

Sara Brautigam was four years ago diagnosed with Postural orthostatic Tachycardia Syndrome (PoTS), a condition which makes her heart stop beating.

The 21-year-old has regular brushes with death and in one year was pronounced clinically dead 36 times.

Ms Brautigam, from Doncaster, said each time her heart stops medics have to inflict pain on her to shock her into coming back to life.
She said: 'When it happens paramedics try and do anything to inflict pain to try and shock me into coming back to life.
'A lot of the time I'll wake up with big bruises. On one occasion they ripped an acrylic nail off but that still didn't make me flinch.'
She also suffers joint hypermobility syndrome which means her joints are more prone to injury and dislocation.
The two combined resulted in her visiting A&E a staggering 64 times in one year.
She said: 'There are signs before it happens - I'll feel dizzy or sick and really tired and then I feel as though I'm falling asleep.I can hear everything around me and feel as though I'm trying to shout but nothing is coming out.
'They say when you die your hearing is the last thing to go and that's been my experience. After an attack I'll wake up and my chest will be killing and I'm really tired.
'I get asked it quite a lot, but there is definitely no bright light. Everything just goes black.
'You can still hear things and there is a voice in my head that is still active and still conscious and it is trying to communicate with those around me. I can remember what people are saying when I black out but have no other awareness of what's going on.'
http://onlinemedicalgists..com/2015/03/woman-who-dies-thirty-six-times-year.html

Ovarian cancer is called "the silent killer" because it usually goes undetected until its advanced stages. It is the fifth leading cause of cancer deaths among American women, according to the Ovarian Cancer National Alliance (OCNA), and strikes one in 55 women in this country.

Ovarian cancer presents a specific danger to women for several reasons. For one, there is no early screening test for ovarian cancer; Pap smears don't detect it. So women with ovarian cancer usually don't see a doctor until they have symptoms, and by then the cancer is usually advanced. Also, symptoms of ovarian cancer are vague and often mimic gastrological or digestive problems. Many women don't think to go to a gynecologist for such symptoms. In some cases a gynecologist will recommend consulting another specialist.
Ovarian cancer is defined in four "stages," with the first three divided into subgroups A, B and C, depending on the cancer's progress.
In Stage I, the cancer is limited to one or both ovaries. In Stage II, it has spread (metastasized) to other reproductive organs. When caught in these stages, women have about a 90 to 95 percent five-year survival rate, according to OCNA.
In Stage III, the cancer has spread to the abdominal lining or lymph nodes. Stage IV cancer has metastasized to the lungs, liver or sites outside the abdomen. When diagnosed in these stages, the chance of five-year survival is only about 25 percent.
In the United States, 75 percent of ovarian cancer cases are detected in Stages III and IV.


SYMPTOMS OF OVARIAN CYST
Early symptoms of ovarian cyst are often mild, making this disease difficult to detect. The symptoms of the cysts vary from woman to woman. However some of the most important early symptoms may include:

An unusual feeling of fullness or discomfort in the pelvic region
Unexplainable indigestion, gas, or bloating that is not relieved with over-the-counter antacids
Pain/discomfort during sexual intercourse or exercise
Abnormal bleeding/unexpected vaginal bleeding
Pressure on the rectum or bladder.
Aching, swelling, pain, or pressure in the lower abdomen
Menstrual irregularities;

Most often these symptoms do not indicate ovarian cancer. However, if you experience them you should discuss them with your clinician.
Early detection of ovarian cancer offers a 90% cure rate. Sadly, a lack of symptoms from this silent disease means that about 75% of ovarian cancer cases will have spread to the abdomen by the time they are detected and, unfortunately, most patients die within five years.


DIAGNOSIS OF OVARIAN CYSTS
Symptomless ovarian cancer is most often detected during a woman's regular gynecological examination. Your physician will palpitate your ovaries during your pelvic and rectal exam for the presence of ovarian cysts or fibroid tumors. If any abnormalities are noted, he will follow up with further testing which may include an ultrasound and chest X-ray. If further testing is required, a laparoscopy may be performed.

New methods for early screening of ovarian cancer are being investigated including ultrasound in conjunction with a blood test. The blood test may detect a cancer protein called CA 125, which is sometimes detected in the blood of women with ovarian cancer.
These tests are useful in evaluating tumor growth, however neither of them has been proven as a reliable way to screen for ovarian cancer. Ultrasound can detect changes, but it does not give enough information alone to diagnose ovarian cancer. The CA 125 blood test can return positive results when no cancer is present due to other conditions a woman may experience including fibroid tumors, endometriosis, pelvic infection, pregnancy, or other non-gynecological problems.
Although these methods of screening for ovarian cancer look promising, further study is needed before either of these tests are routinely used to screen for ovarian cancer.


RISK FACTORS OF OVARIAN CYST
Age : specifically women who have gone through menopause. Women over the age of 50 are at greater risk
Lifestlye: Obesity, Smoking
Child bearing or Breastfeeding: However, having two or three children can cut your risk by as much as 30% over women who never conceive or give birth. Having five or more children reduces the risk up to 50%, and breastfeeding your children can further reduce your risk.
Women who use oral contraceptives for at least five years reduce their chance of developing ovarian cancer by half for the short-term following use and possibly for lifetime. The longer you use the pill, the lower your risk.
Family or personal history of ovarian cancer: An immediate (mother, sister, or daughter) family member who has had ovarian cancer increases your risk of developing this disease about three times, giving you a 5% to 7% risk of future ovarian cancer. When the cause is genetic, ovarian cancer usually shows up a decade earlier in each successive generation. (If your mother had ovarian cancer in her 60s, you stand a good chance that this disease will develop in you in your 50s.) Genetic counseling is a good idea for women with a family history of breast or ovarian cancers. Women with a family history may opt for oophorectomy, although this procedure does not offer absolute protection it does reduce risk by 75% to 90%

Others: Research has determined that women who use powders to dust their genital areas have a 60% higher risk of ovarian cancer. Feminine deodorant sprays can almost double your risk. Tubal ligation reduces a woman's risk up to 70%.


TREATMENT OF OVARIAN CYST
The treatment for ovarian cancer varies according to a number of factors. For most women, the first treatment is also a diagnostic procedure which involves surgery to determine the extent to which the disease has spread. As a result of surgery, the cancer will be staged . Stages range from I to IV, with I being the earliest and IV being the most advanced stage. Treatment of ovarian cancer is based on the stage and grade of the disease. A pathologist will determine the grade (how likely it is to spread) of the malignancy.

Hysterectomy with salpingo- oophorectomy (removal the fallopian tubes and one or both ovaries) will most often follow a diagnosis of ovarian cancer. Young women who still desire children and who have certain types of early ovarian cancer confined to one ovary may be able to have only the diseased ovary removed.
Chemotherapy or radiation will follow the hysterectomy based on individual cases.

Remember, the best way to detect ovarian cancer is by regular pelvic examinations. See your gynecologist for a Pap smear (screens for cervical cancer only) and pelvic/rectal exam yearly or as your physician determines best for you.

http://onlinemedicalgists..com/2015/03/ovarian-cyst-silent-killer.html

dia ris god o

pix plsss

booked